Speakers | Psychedelic Science

Programming Tracks

Keynote

Big ideas and high-profile speakers exploring the integration of psychedelics into broader society and culture.

Black Liberation

A half-day series on ways plant medicine can support Black communities in healing from systemic and interpersonal racism, trauma, and exploitation.

Business

The infrastructure for scaling safe and responsible access to psychedelics, including finance, drug development, regulatory, clinics and service centers, technology, and community institutions.

Community

Dialogues and stories about psychedelics from the perspectives of unique and intersectional communities.

Science

The latest insights on the neuroscience, pharmacology, and chemistry of psychedelics, and the quest to understand their mechanisms of action.

Statewide

A single-day forum focused on the new systems of state-regulated access to psychedelic experiences in Colorado and Oregon.

Veterans

A single-day forum for veterans, first responders, and their families about the growing movement to bring psychedelic healing to their communities.

Doblin

Personal selections from MAPS Founder Rick Doblin, focusing on the living legacy and pioneers of psychedelic research, therapy, and culture.

Plant Medicine

The world of ethnobotanical practices that use psychedelic plant medicines, including Indigenous, traditional, spiritual, and contemporary approaches.

Policy

The legislative, judicial, and regulatory foundations required to create and manage safe and responsible access to psychedelics and a post-prohibition society.

Society

The intersection of psychedelics and society, including popular culture, the arts and music, media, religion and spirituality, ethnicity and culture, and the psychedelic community itself.

Studies

New research spanning a variety of fields, including clinical trials, naturalistic use, risk & safety, public opinion, health and wellness, religion & spirituality, and global culture.

Trials

Findings and updates from clinical trials studying the potential of psychedelics in the treatment of serious mental illness and neurological disorders.

Therapy

Deep discussions for clinicians and facilitators from intake to integration, including critical viewpoints on evidence-based practices, education and training, ethics and accountability, and the delivery of care.